|Institutional Source||Beutler Lab|
|Gene Name||ring finger protein 213|
Genbank: XM_001477846.2; Ensembl: ENSMUST00000131035, ENSMUST00000082107, ENSMUST00000093902, ENSMUST00000169768, ENSMUST00000172235
|Essential gene?||Non essential (E-score: 0.000)|
|Stock #||R0765 (G1)|
|Chromosomal Location||119393100-119487418 bp(+) (GRCm38)|
|Type of Mutation||critical splice donor site (1 bp from exon)|
|DNA Base Change (assembly)||G to A at 119423095 bp (GRCm38)|
|Amino Acid Change|
|Ref Sequence||ENSEMBL: ENSMUSP00000115063 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000093902] [ENSMUST00000131035]|
|AlphaFold||no structure available at present|
|Meta Mutation Damage Score||0.9581|
|Coding Region Coverage||
|Validation Efficiency||100% (62/62)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit decreased body weight and circulating glucose level but normal glucose tolerance, insulin sensitivity, insulin plasma levels and leptin plasma levels. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Rnf213||
(F):5'- GACACATGTATCTGCTCGTGTCCC -3'
(R):5'- CAAGAGTGCAAGAGGACTTCCCTG -3'
(F):5'- atcttcctgcttccaatccc -3'
(R):5'- GCAAGAGGACTTCCCTGTATATGAC -3'